Panbela Therapeutics, Inc. Proceeds from Stock Options Exercised
Panbela Therapeutics, Inc. reported Proceeds from Stock Options Exercised of $28.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2019-03-22.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2019-03-22
- Panbela Therapeutics, Inc. proceeds from stock options exercised for the quarter ending 2017-12-31 was $0.00.
- Panbela Therapeutics, Inc. proceeds from stock options exercised for the quarter ending 2017-09-30 was $0.00.
- Panbela Therapeutics, Inc. proceeds from stock options exercised for the quarter ending 2017-06-30 was $21.00K.
- Panbela Therapeutics, Inc. proceeds from stock options exercised for the quarter ending 2017-03-31 was $7.00K.
- Panbela Therapeutics, Inc. proceeds from stock options exercised for fiscal 2017 was $28.00K.
- Panbela Therapeutics, Inc. proceeds from stock options exercised for fiscal 2015 was $762.00K, a 79.72% increase from fiscal 2014.
- Panbela Therapeutics, Inc. proceeds from stock options exercised for fiscal 2014 was $424.00K.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $0.00 derived: sum of 2 quarters · filed 2019-03-22 | $21.00K derived: sum of 3 quarters · filed 2019-03-22 | $28.00K 10-K · filed 2019-03-22 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $21.00K derived: sum of 2 quarters · filed 2018-11-05 | $28.00K 10-Q · filed 2018-11-05 | |
| 2017-06-30 | $21.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $28.00K 10-Q · filed 2018-08-13 | ||
| 2017-03-31 | $7.00K 10-Q · filed 2018-05-14 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | $0.00 derived: sum of 2 quarters · filed 2017-03-30 | $353.00K derived: sum of 3 quarters · filed 2017-03-30 | $762.00K 10-K · filed 2017-03-30 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $353.00K derived: sum of 2 quarters · filed 2016-11-10 | $762.00K 10-Q · filed 2016-11-10 | $1.18M derived: sum of 4 quarters · filed 2016-11-10 |
| 2015-06-30 | $353.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $762.00K 10-Q · filed 2016-08-11 | $1.18M derived: sum of 3 quarters · filed 2016-08-11 | |
| 2015-03-31 | $409.00K 10-Q · filed 2016-05-12 | $822.00K derived: sum of 2 quarters · filed 2016-05-12 | ||
| 2014-12-31 | $413.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-08 | $424.00K 10-K · filed 2016-03-08 | ||
| 2014-09-30 | $11.00K 10-Q · filed 2015-11-16 |